CEO Dr James Garner featured on ‘The Health Kick Podcast’ to discuss the company’s latest achievements

Kazia CEO, Dr James Garner was recently featured on Stockhead’s new podcast series, “The Health Kick Podcast” with Tim Boreham.

In the interview, Dr Garner discusses:

  • The company’s journey from Novogen to Kazia and building a world-class, 21st century drug developer
  • Kazia’s recent achievements and milestones, including the company’s win of an inaugural ANZLF Trans-Tasman Innovation and Growth Award
  • The blood brain barrier and how Kazia’s lead candidate, GDC-0084, treats glioblastoma, the most aggressive form of brain cancer

Kazia will be presenting at the upcoming Australia Biotech Invest & Partnering conference on Thursday 31 October at the Melbourne Convention and Exhibition Centre.

 

For more information on Kazia register your interest below.

Register Interest